Importance of Zika Virus NS5 Protein for Viral Replication

被引:32
作者
Elshahawi, Hesham [1 ]
Syed Hassan, Sharifah [1 ,2 ]
Balasubramaniam, Vinod [1 ]
机构
[1] Monash Univ Malaysia, Jeffrey Cheah Sch Med & Hlth Sci, Jalan Lagoon Selatan, Subang Jaya 47500, Selangor, Malaysia
[2] Monash Univ Malaysia, Trop Med & Biol Multidisciplinary Platform, Jalan Lagoon Selatan, Subang Jaya 47500, Selangor, Malaysia
来源
PATHOGENS | 2019年 / 8卷 / 04期
关键词
Zika; NS5; Flavivirus; Arbovirus; TBK1; STAT2; IFN1; IFN3; RdRp; MTase; I INTERFERON-PRODUCTION; RNA-SYNTHESIS; NUCLEOSIDE INHIBITORS; ADAPTER PROTEIN; III INTERFERON; INFECTION; METHYLTRANSFERASE; EPIDEMIOLOGY; POLYMERASE; OUTBREAK;
D O I
10.3390/pathogens8040169
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Zika virus is the latest addition to an ever-growing list of arboviruses that are causing outbreaks with serious consequences. A few mild cases were recorded between 1960 and 1980 until the first major outbreak in 2007 on Yap Island. This was followed by more severe outbreaks in French Polynesia (2013) and Brazil (2015), which significantly increased both Guillain-Barre syndrome and microcephaly cases. No current vaccines or treatments are available, however, recent studies have taken interest in the NS5 protein which encodes both the viral methyltransferase and RNA-dependent RNA polymerase. This makes it important for viral replication alongside other important functions such as inhibiting the innate immune system thus ensuring virus survival and replication. Structural studies can help design inhibitors, while biochemical studies can help understand the various mechanisms utilized by NS5 thus counteracting them might inhibit or abolish the viral infection. Drug repurposing targeting the NS5 protein has also proven to be an effective tool since hundreds of thousands of compounds can be screened therefore saving time and resources, moreover information on these compounds might already be available especially if they are used to treat other ailments.
引用
收藏
页数:12
相关论文
共 79 条
[1]   Therapeutic Approaches for Zika Virus Infection of the Nervous System [J].
Abrams, Rachel P. M. ;
Solis, Jamie ;
Nath, Avindra .
NEUROTHERAPEUTICS, 2017, 14 (04) :1027-1048
[2]   Pathogen recognition and innate immunity [J].
Akira, S ;
Uematsu, S ;
Takeuchi, O .
CELL, 2006, 124 (04) :783-801
[3]  
[Anonymous], ZIK SIT REP
[4]  
[Anonymous], HEP B C TREATM
[5]  
Best SM, 2017, J VIROL, V91, DOI [10.1128/JVI.01970-16, 10.1128/jvi.01970-16]
[6]   The FDA-approved drug sofosbuvir inhibits Zika virus infection [J].
Bullard-Feibelman, Kristen M. ;
Govero, Jennifer ;
Zhu, Zhe ;
Salazar, Vanessa ;
Veselinovic, Milena ;
Diamond, Michael S. ;
Geiss, Brian J. .
ANTIVIRAL RESEARCH, 2017, 137 :134-140
[7]  
CDC, FLAV
[8]  
CDC, STAT MAPS ZIK VIR
[9]   Selective Activation of Type II Interferon Signaling by Zika Virus NS5 Protein [J].
Chaudhary, Vidyanath ;
Yuen, Kit-San ;
Chan, Jasper Fuk-Woo ;
Chan, Ching-Ping ;
Wang, Pei-Hui ;
Cai, Jian-Piao ;
Zhang, Shuo ;
Liang, Mifang ;
Kok, Kin-Hang ;
Chan, Chi-Ping ;
Yuen, Kwok-Yung ;
Jin, Dong-Yan .
JOURNAL OF VIROLOGY, 2017, 91 (14)
[10]   Structures of NS5 Methyltransferase from Zika Virus [J].
Coloma, Javier ;
Jain, Rinku ;
Rajashankar, Kanagalaghatta R. ;
Garcia-Sastre, Adolfo ;
Aggarwal, Aneel K. .
CELL REPORTS, 2016, 16 (12) :3097-3102